Cleared Traditional

K222086 - Inogen Rove 4 Portable Oxygen Concentrator

K222086 is an FDA 510(k) clearance for Inogen Rove 4 Portable Oxygen Concentrator, manufactured by Inogen. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 147-day FDA review.

K222086 · Inogen · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
147d
Days
Class 2
Risk

K222086 is an FDA 510(k) clearance for the Inogen Rove 4 Portable Oxygen Concentrator. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Inogen (Goleta, US). The FDA issued a Cleared decision on December 9, 2022 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Inogen devices

FDA 510(k) Submission Details - K222086

510(k) Number K222086 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2022
Decision Date December 09, 2022
Days to Decision 147 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 140d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 91
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K222086.
Portable Oxygen Concentrator (Model: P2-E7, P2-E)
K223379 · Qingdao Kingon Medical Science and Technology Co., Ltd. · Jun 2023
Oxus Sieve Beds
K211056 · Oxus, Inc. · May 2023
Oxygen Concentrator model 8F-3A, Oxygen Concentrator model 8F-5A
K213825 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Apr 2023
Oxygen Concentrator, Model JAY-5AW
K213210 · Longfian Scitech Co., Ltd. · Dec 2022
Portable Oxygen Concentrator, model: P2-E6
K210371 · Qingdao Kingon Medical Science and Technology Co., Ltd. · Jun 2022
Oxygen Concentrator
K202389 · Foshan Mic Medical Technology Co., Ltd. · Apr 2022